Micro and nanofluidics for diagnostics

Purpose and goal

Experimental results at the proof-of-principle stage dealing with DNA handling and imaging were generated and a patentability survey was conducted by LU Innovation with positive results. Patient work has not yet begun. Several new innovative projects have been launched, in collaboration with new partners. Investigations of the need for our methods have been positive and inspired the writing of an SFF application. Strategies for commercialization and IP that the main applicant was to develop have been partially achieved and are ongoing.

Expected results and effects

Our technology has developed a lot during the course of the project. Developments have been well received by the research field and will be presented at the field´s largest conference - TAS. The studies of existing methods have resulted in two review articles that will be completed in 2018. Finding industrial partners or corporate stakeholders has been more difficult. A project with Biomode SA is underway, where we develop microfluidic solutions on a device that detects bacterial infections. Very positive feedback from leading Bionano Genomics has inspired further IP related work.

Planned approach and implementation

JB has attended national and international conferences focusing on micro / nanofluidics. Dissemination and networking at these events was successful and resulted in new projects. Much focus has been placed on the development of the techniques, studies of existing methods, writing of review articles and an SFF application. A more focused collaboration between LU and Acreo regarding the possibilities of commercializing these ideas could probably have driven the project more on this front, but the work continues.